We are live on ! Find out more
LJPC

La Jolla Pharmaceutical Company
LJPC

Delisted

LJPC was delisted on the 19th of August, 2022.

Back to rankings

100 hedge funds and large institutions have $871M invested in La Jolla Pharmaceutical Company in 2018 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 34 increasing their positions, 25 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 14

36% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 25

8% more capital invested

Capital invested by funds: $808M → $871M (+$62.7M)

8% more funds holding

Funds holding: 93 → 100 (+7)

17% less funds holding in top 10

Funds holding in top 10: 6 → 5 (-1)

56% less call options, than puts

Call options by funds: $5.85M | Put options by funds: $13.4M

Holders
100
Holders Change
+7
Holders Change %
+7.53%
% of All Funds
2.29%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.11%
New
22
Increased
34
Reduced
25
Closed
14
Calls
$5.85M
Puts
$13.4M
Net Calls
-$7.56M
Net Calls Change
-$2.71M

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$29.8M
2
Jennison Associates
Jennison Associates
New York
+$29.6M
3
TCM
Tang Capital Management
California
+$22.5M
4
BC
Broadfin Capital
New York
+$20.2M
5
State Street
State Street
Massachusetts
+$20.1M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$66.9M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$8.4M
3
GTC
Ghost Tree Capital
New York
-$6.44M
4
ORI
Oak Ridge Investments
Illinois
-$1.9M
5
MWNA
Marshall Wace North America
New York
-$1.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$4.08M +$4.3M +133,372 +3,536%
AllianceBernstein
27
AllianceBernstein
Tennessee
$3.34M +$3.06M +95,000 +556%
DZ Bank
28
DZ Bank
Germany
$3.25M +$3.52M +109,261 New
Deutsche Bank
29
Deutsche Bank
Germany
$3.09M +$2.08M +64,571 +164%
UBS Group
30
UBS Group
Switzerland
$2.91M +$2.65M +82,109 +529%
Charles Schwab
31
Charles Schwab
California
$2.57M +$359K +11,132 +15%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$2.57M +$80.9K +2,508 +3%
Allianz Asset Management
33
Allianz Asset Management
Germany
$2.47M -$50.7K -1,574 -2%
EU
34
Emory University
Georgia
$2.3M +$829K +25,703 +50%
ACM
35
Asymmetry Capital Management
California
$1.66M +$1.8M +55,864 New
JGC
36
J. Goldman & Co
New York
$1.65M +$1.78M +55,300 New
Morgan Stanley
37
Morgan Stanley
New York
$1.46M -$139K -4,321 -8%
Bank of America
38
Bank of America
North Carolina
$1.43M +$568K +17,631 +58%
Citigroup
39
Citigroup
New York
$1.41M +$925K +28,676 +153%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$1.26M – – –
AI
41
Axiom Investors
Connecticut
$1.23M -$728K -22,585 -35%
TCIM
42
TIAA CREF Investment Management
New York
$1.22M -$52.6K -1,632 -4%
HT
43
HAP Trading
New York
$1.09M +$1.18M +36,636 New
PCM
44
Prelude Capital Management
New York
$1.01M +$1.09M +33,956 New
Swiss National Bank
45
Swiss National Bank
Switzerland
$986K +$119K +3,700 +13%
TA
46
Teachers Advisors
New York
$945K – – –
VEA
47
Virtus ETF Advisers
New York
$928K +$541K +16,779 +117%
Citadel Advisors
48
Citadel Advisors
Florida
$891K +$964K +29,906 New
TI
49
Trexquant Investment
Connecticut
$795K +$860K +26,682 New
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$790K -$33.1K -1,026 -4%
1
2
3 4 5

LJPC Hedge Fund Activity: Q1 2018 in Review

100 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical Company (LJPC) for Q1 2018, worth a combined $871M — up 7.8% from $808M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new LJPC positions and 14 closed out — a net gain of 8 holders — while 34 added to existing stakes and 25 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $29.8M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $66.9M sold.

  • 100 institutional investors held La Jolla Pharmaceutical Company (LJPC) as of Q1 2018, up from 93 in Q4 2017.
  • Funds reported $871M of La Jolla Pharmaceutical Company stock for Q1 2018, up 7.8% quarter-over-quarter.
  • 22 funds opened new La Jolla Pharmaceutical Company positions in Q1 2018 and 14 closed out, a net change of +8 holders.
  • The largest La Jolla Pharmaceutical Company buyer in Q1 2018 was Perceptive Advisors, an estimated $29.8M added.
  • The largest La Jolla Pharmaceutical Company seller in Q1 2018 was Consonance Capital Management, an estimated $66.9M sold.

Based on aggregated 13F filings for Q1 2018.